Targeting Intestinal Fibrosis in Inflammatory Bowel Disease:Accelerate Time To Market For GI Clinical Trials

ON DEMAND WEBINAR
Duration: 1 hour

We are a GI-focused CRO with proven in-depth GI-specific knowledge throughout the entire organization and finely tuned operational workflows developed by our industry-leading KOLs.

Watch leading industry experts discuss Targeting Intestinal Fibrosis in Inflammatory Bowel Disease. Join our expert panel for discussions on:

Mechanisms of fibrosis in different organs and common pathways
Treatments for fibrosis in other organs systems
Assessment and clinical management of fibrostenotic disease in patients with IBD
Developing new imaging, biomarker, and clinical endpoints for drug development
Exploring the pipeline of drug development for fibrostenosis in IBD

This is part 1 of our Discovery Accelerated Webinar Series. Future webinar titles include:

Drug Development in NASH
Real World Evidence in Drug Development in IBD

SPEAKERS

Thomas Wynn, PhD
Pfizer, VP Discovery
Immunology and Inflammation, MA

Julian Panes, MD
Director, IBD Unit Hospital Clinic
Barcelona

Florian Rieder, MD
Director, IBD Research
Cleveland Clinic Foundation, OH

First Name *

Last Name *

Company Email *

Job Title *

Company *

Company Type *

Dive Publication